首页> 外国专利> IL13Rα2 binding agents and their use in cancer therapy

IL13Rα2 binding agents and their use in cancer therapy

机译:IL13Rα2结合剂及其在癌症治疗中的应用

摘要

Provided are specific binding molecules or fragments thereof that bind to an epitope of IL13Rα2, a receptor polypeptide that is preferentially found on the surface of cancer cells but not healthy cells. Exemplary specific binding molecules include a fragment of an IL13Rα2 binding molecule and a signal transduction function of the signaling domain of a T cell signaling protein, a peptide modulator of T cell activation or an enzyme component of a labeling system. A bispecific binding molecule comprising a peptide that provides a function. Also provided are polynucleotides, vectors, host cells, pharmaceutical compositions, and solid tumor diseases (eg, polymorphisms) that encode such specific binding molecules (eg, bispecific binding molecules). A method of preventing, treating or ameliorating symptoms associated with cancer diseases such as glioblastoma). [Selection] Figure 1
机译:提供与IL13Rα2的表位结合的特异性结合分子或其片段,IL13Rα2是优先在癌细胞表面而非健康细胞表面上发现的受体多肽。示例性的特异性结合分子包括IL13Rα2结合分子的片段和T细胞信号传导蛋白的信号传导域的信号转导功能,T细胞活化的肽调节剂或标记系统的酶组分。双特异性结合分子,其包含提供功能的肽。还提供了编码这样的特异性结合分子(例如,双特异性结合分子)的多核苷酸,载体,宿主细胞,药物组合物和实体瘤疾病(例如,多态性)。一种预防,治疗或改善与胶质母细胞瘤等癌症疾病相关的症状的方法。 [选择]图1

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号